Variant report
Variant | nsv1067008 |
---|---|
Chromosome Location | chr16:82273372-82287173 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146393056 | chr16:82273615-82273616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549284717 | chr16:82273689-82273690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs8046383 | chr16:82273722-82273723 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs8062016 | chr16:82273750-82273751 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs549373358 | chr16:82273766-82273767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570863439 | chr16:82273828-82273829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1011432 | chr16:82273829-82273830 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs186673620 | chr16:82273833-82273834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553551392 | chr16:82273867-82273868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189854677 | chr16:82273871-82273872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534129106 | chr16:82273874-82273875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556067114 | chr16:82273893-82273894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574396121 | chr16:82273899-82273900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570645095 | chr16:82273900-82273901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139781223 | chr16:82273965-82273966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75725284 | chr16:82273970-82273971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145300496 | chr16:82273971-82273972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545554538 | chr16:82273972-82273973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560360338 | chr16:82273985-82273986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148776806 | chr16:82273994-82273995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142310793 | chr16:82274033-82274034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561095125 | chr16:82274059-82274060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531504045 | chr16:82274126-82274127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7205841 | chr16:82274146-82274147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182811109 | chr16:82274190-82274191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2967333 | chr16:82274207-82274208 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs71402003 | chr16:82274219-82274220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575038255 | chr16:82274227-82274228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547517896 | chr16:82274248-82274249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs151281089 | chr16:82274258-82274259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115034838 | chr16:82274260-82274261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7187181 | chr16:82274265-82274266 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs73596915 | chr16:82274299-82274300 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs538557221 | chr16:82274304-82274305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141539354 | chr16:82274306-82274307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144162033 | chr16:82274321-82274322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375190142 | chr16:82274322-82274323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs57199827 | chr16:82274330-82274331 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs115741544 | chr16:82274357-82274358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368237011 | chr16:82274360-82274361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572454868 | chr16:82274365-82274366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188227075 | chr16:82274366-82274367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145384273 | chr16:82274389-82274390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192799361 | chr16:82274454-82274455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554481881 | chr16:82274463-82274464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs59936413 | chr16:82274471-82274472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546157071 | chr16:82274510-82274511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543346036 | chr16:82274523-82274524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562576780 | chr16:82274532-82274533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538710994 | chr16:82274577-82274578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16461572 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:82273600-82274000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr16:82273600-82274000 | Enhancers | NHEK | skin |
3 | chr16:82273600-82274200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr16:82274000-82274200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr16:82274200-82275000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr16:82275000-82275400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr16:82277200-82278000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr16:82281600-82282400 | Enhancers | Brain Anterior Caudate | brain |
9 | chr16:82281800-82283400 | Enhancers | Gastric | stomach |